surmount-1 trial tirzepatide weight loss non-diabetic once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 SURMOUNT-1: Tirzepatide Drastically Reduces Weight

Kaufman Were back, focusing on GLP-1-enhancing drugs

If needle anxiety is making your tirzepatide injections stressful, several approaches can help

Medical Health offers semaglutide from $199/mo vs Hims ($199-299/mo), Ro ($399/mo), and Calibrate ($299+/mo with 12-month commitment)

15 demonstrating powerful inhibition of food intake after ICV administration of GLP-1, an effect that could be blocked by the specific receptor antagonists exendin 939, which also enhanced spontaneous as well as neuropeptide Y-stimulated food intake

Per-milligram pricing sits below most premium US suppliers without sacrificing purity, so lower cost does not come at the expense of quality